Oncotarget

Research Papers:

Long noncoding RNA SFTA1P promoted apoptosis and increased cisplatin chemosensitivity via regulating the hnRNP-U-GADD45A axis in lung squamous cell carcinoma

Ling Li, Ji-Ye Yin, Fa-Zhong He, Ma-Sha Huang, Tao Zhu, Yuan-Feng Gao, Yi-Xin Chen, Dong-Bo Zhou, Xiang Chen, Lun-Quan Sun, Wei Zhang, Hong-Hao Zhou and Zhao-Qian Liu _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:97476-97489. https://doi.org/10.18632/oncotarget.22138

Metrics: PDF 715 views  |   HTML 975 views  |   ?  


Abstract

Ling Li1,2, Ji-Ye Yin1,2, Fa-Zhong He1,2, Ma-Sha Huang1,2, Tao Zhu1,2, Yuan-Feng Gao1,2, Yi-Xin Chen1,2, Dong-Bo Zhou3, Xiang Chen4, Lun-Quan Sun5, Wei Zhang1,2, Hong-Hao Zhou1,2 and Zhao-Qian Liu1,2

1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P. R. China

2Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, P. R. China

3Department of Gerontology, Xiangya Hospital, Central South University, Changsha 410008, P. R. China

4Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, P. R. China

5Center for Molecular Medicine, Xiangya Hospital, Key Laboratory of Molecular Radiation Oncology of Hunan Province, Central South University, Changsha 410008, P. R. China

Correspondence to:

Zhao-Qian Liu, email: liuzhaoqian63@126.com

Keywords: lung squamous cell carcinoma; long noncoding RNA SFTA1P; hnRNP-U- GADD45A; apoptosis; cisplatin chemosensitivity

Received: July 28, 2017     Accepted: August 24, 2017     Published: October 27, 2017

ABSTRACT

Chemotherapeutic insensitivity remains one of the major obstacles in clinical treatment of lung squamous cell carcinoma (LSCC). Recently, increasing evidence has suggested that long non-coding RNAs (lncRNAs) promote tumorigenesis in many cancer types. However, the potential biological roles and regulatory mechanisms of lncRNAs in response to cisplatin treatment are poorly understood. Here, we found that lncRNA SFTA1P (surfactant associated 1, pseudogene), highly expressed in lung, was down-regulated in LSCC tissues and could be induced upon cisplatin treatment in LSCC cells. Elevated SFTA1P induced apoptosis and enhanced the sensitivity to cisplatin of LSCC cells. We further identified that hnRNP-U (heterogeneous nuclear ribonucleoprotein U) was down-regulated in LSCCs and positively correlated with patients’ poor prognosis as well as SFTA1P. Mechanistic studies revealed that SFTA1P could up-regulate hnRNP-U expression. In addition, we identified that hnRNP-U enhanced cisplatin-induced apoptosis through up-regulation of GADD45A, high expression of which was correlated with good prognosis in LSCC patients. Our findings demonstrated that SFTA1P might serve as a useful biomarker for LSCC diagnosis and a predictor for cisplatin chemotherapy response in patients with LSCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 22138